Do topical calcineurin inhibitors treat atopic dermatitis?

Atopic dermatitis is an inflammatory condition in which the skin barrier is easily irritated and itchy. Topical calcineurin inhibitors dampen immune activity in the skin, helping settle redness, itch and flare activity. They do not replace regular moisturising, because barrier care remains part of controlling dryness and reducing irritation. A clinician may choose them for areas such as the face, eyelids, neck or skin folds, where prolonged steroid exposure needs particular care. The medicine may sting or feel warm at first, especially on actively inflamed skin.

Use the prescribed amount on clean, dry affected skin and wash your hands afterwards unless the hands are being treated. Apply moisturiser as advised, avoid fragranced products that trigger your symptoms, and protect treated skin from unnecessary sun exposure. Do not cover the area with a tight dressing unless instructed. Keep using the plan during early flare signs if your clinician has given you a flare routine, rather than changing the frequency independently.

Contact your clinician if the treated skin develops spreading redness, pus, increasing pain, blisters or fever, as these can signal infection or another problem. Arrange a review if the flare keeps returning despite correct use, if stinging remains severe, or if the diagnosis is uncertain. Urgent care is appropriate for facial swelling, breathing difficulty or a rapidly worsening widespread reaction.

Ask which areas should receive the medicine, whether it is for active flares or maintenance, how to combine it with moisturiser, and when to stop or return for review. Ask what infection signs to watch for if the skin is cracked or weeping.